Safety of SARS-CoV-2 vaccines: a systematic review and meta-analysis of randomized controlled trials

M Chen, Y Yuan, Y Zhou, Z Deng, J Zhao… - Infectious diseases of …, 2021 - Springer
Background Various modalities of vaccines against coronavirus disease 2019 (COVID-19),
based on different platforms and immunization procedures, have been successively …

Bacterial outer membrane vesicles as a candidate tumor vaccine platform

S Wang, J Guo, Y Bai, C Sun, Y Wu, Z Liu… - Frontiers in …, 2022 - frontiersin.org
Cancer represents a serious concern for human life and health. Due to drug resistance and
the easy metastasis of tumors, there is urgent need to develop new cancer treatment …

Effectiveness of a serogroup B outer membrane vesicle meningococcal vaccine against gonorrhoea: a retrospective observational study

WE Abara, KT Bernstein, FMT Lewis… - The Lancet Infectious …, 2022 - thelancet.com
Background Declining antimicrobial susceptibility to current gonorrhoea antibiotic treatment
and inadequate treatment options have raised the possibility of untreatable gonorrhoea …

[HTML][HTML] Meningococcal vaccination: recommendations of the advisory committee on immunization practices, United States, 2020

SA Mbaeyi - MMWR. Recommendations and Reports, 2020 - cdc.gov
This report compiles and summarizes all recommendations from CDC's Advisory Committee
on Immunization Practices (ACIP) for use of meningococcal vaccines in the United States …

[HTML][HTML] Effectiveness of a meningococcal group B vaccine (4CMenB) in children

J Castilla, M García Cenoz, R Abad… - … England Journal of …, 2023 - Mass Medical Soc
Abstract Background In September 2015, the four-component, protein-based meningococcal
serogroup B vaccine (4CMenB; Bexsero) became available for private purchase in Spain …

Vaccination of infants with meningococcal group B vaccine (4CMenB) in England

SN Ladhani, N Andrews, SR Parikh… - … England Journal of …, 2020 - Mass Medical Soc
Abstract Background In September 2015, the United Kingdom introduced the
multicomponent meningococcal group B vaccine (4CMenB, Bexsero) into its publicly funded …

Effectiveness and impact of the 4CMenB vaccine against invasive serogroup B meningococcal disease and gonorrhoea in an infant, child, and adolescent programme …

B Wang, L Giles, P Andraweera, M McMillan… - The Lancet Infectious …, 2022 - thelancet.com
Background A programme of vaccination with the four-component serogroup B
meningococcal (4CMenB) vaccine was introduced in South Australia for infants and children …

[图书][B] Uncertainty: How it makes science advance

K Kampourakis, K McCain - 2019 - books.google.com
Scientific knowledge is the most solid and robust kind of knowledge that humans have
because of the self-correcting character inherent in its own processes. Nevertheless, anti …

Role of progesterone, cerclage and pessary in preventing preterm birth in twin pregnancies: A systematic review and network meta-analysis

F D'Antonio, V Berghella, D Di Mascio… - European Journal of …, 2021 - Elsevier
Objective To determine the role of progesterone, pessary and cervical cerclage in reducing
the risk of (preterm birth) PTB in twin pregnancies and compare these interventions using …

[HTML][HTML] Immunogenicity, safety and efficacy of the dengue vaccine TAK-003: a meta-analysis

ME Flacco, A Bianconi, G Cioni, M Fiore, GL Calò… - Vaccines, 2024 - mdpi.com
The TAK-003 dengue vaccine was licensed in Europe in December 2022, and the official
recommendations from most EU countries are still under formulation. To support …